Cerebellar atrophy in a chronic phenytoin user. Coronal T2-weighted MRI sequence showing marked atrophy of the cerebellum, disproportionate to that observed in the rest of the brain parenchyma, in an 18-year-old patient who had been treated with phenytoin since the age of 5 years.